TreeWAS – Variant ID: rs2858942

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T39.1 4-Aminophenol derivatives	0.035	0.965	0.000
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.034	0.966	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.033	0.967	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.030	0.970	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.030	0.970	0.000
I69 Sequelae of cerebrovascular disease	0.030	0.970	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.029	0.971	0.000
I69.3 Sequelae of cerebral infarction	0.029	0.971	0.000
I69.1 Sequelae of intracerebral haemorrhage	0.028	0.972	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.027	0.973	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.026	0.974	0.000
T39.0 Salicylates	0.026	0.974	0.000
T50.8 Diagnostic agents	0.025	0.975	0.000
T40.2 Other opioids	0.025	0.975	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.025	0.975	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.024	0.976	0.000
T39.4 Antirheumatics, not elsewhere classified	0.024	0.976	0.000
T39.2 Pyrazolone derivatives	0.024	0.976	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.024	0.976	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.024	0.976	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.024	0.976	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.023	0.977	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.023	0.977	0.000
T46.1 Calcium-channel blockers	0.023	0.977	0.000
T36 Poisoning by systemic antibiotics	0.023	0.977	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.022	0.978	0.000
T50.4 Drugs affecting uric acid metabolism	0.022	0.978	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.021	0.978	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.021	0.979	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.021	0.979	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.021	0.979	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.021	0.979	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.021	0.979	0.000
T50.7 Analeptics and opioid receptor antagonists	0.021	0.979	0.000
T50.5 Appetite depressants	0.021	0.979	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.021	0.979	0.000
T50.1 Loop [high-ceiling] diuretics	0.021	0.979	0.000
T50.0 Mineralocorticoids and their antagonists	0.021	0.979	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.021	0.979	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.020	0.979	0.000
T45.5 Anticoagulants	0.020	0.979	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.020	0.980	0.000
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.020	0.980	0.000
T48.5 Anti-common-cold drugs	0.020	0.980	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.020	0.980	0.000
T46.7 Peripheral vasodilators	0.020	0.980	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.020	0.980	0.000
T40.3 Methadone	0.020	0.980	0.000
T40.6 Other and unspecified narcotics	0.020	0.980	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.020	0.980	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.019	0.980	0.000
D27 Benign neoplasm of ovary	0.020	0.980	0.000
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.019	0.981	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.019	0.981	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.019	0.981	0.000
T40.8 Lysergide [LSD]	0.019	0.981	0.000
T40.7 Cannabis (derivatives)	0.019	0.981	0.000
T40.0 Opium	0.019	0.981	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.019	0.981	0.000
T40.5 Cocaine	0.019	0.981	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.018	0.982	0.000
T49.9 Topical agent, unspecified	0.018	0.982	0.000
T49.8 Other topical agents	0.018	0.982	0.000
T49.7 Dental drugs, topically applied	0.018	0.982	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.018	0.982	0.000
T49.5 Ophthalmological drugs and preparations	0.018	0.982	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.018	0.982	0.000
T49.3 Emollients, demulcents and protectants	0.018	0.982	0.000
T49.2 Local astringents and local detergents	0.018	0.982	0.000
T49.1 Antipruritics	0.018	0.982	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.018	0.982	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.017	0.982	0.000
T45.8 Other primarily systemic and haematological agents	0.017	0.982	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.017	0.982	0.000
T45.6 Fibrinolysis-affecting drugs	0.017	0.982	0.000
T45.4 Iron and its compounds	0.017	0.982	0.000
T45.3 Enzymes, not elsewhere classified	0.017	0.982	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.017	0.982	0.000
T48.4 Expectorants	0.017	0.982	0.000
T48.3 Antitussives	0.017	0.982	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.017	0.982	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.017	0.982	0.000
T48.0 Oxytocic drugs	0.017	0.982	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.017	0.983	0.000
T38.1 Thyroid hormones and substitutes	0.017	0.983	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.017	0.983	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.017	0.983	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.017	0.983	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.017	0.983	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.017	0.983	0.000
T44.0 Anticholinesterase agents	0.017	0.983	0.000
T45.2 Vitamins, not elsewhere classified	0.017	0.983	0.000
T36.8 Other systemic antibiotics	0.017	0.983	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.017	0.983	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.017	0.983	0.000
T36.3 Macrolides	0.017	0.983	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.016	0.983	0.000
T36.9 Systemic antibiotic, unspecified	0.016	0.984	0.000
T36.7 Antifungal antibiotics, systemically used	0.016	0.984	0.000
T36.6 Rifamycins	0.016	0.984	0.000
T36.5 Aminoglycosides	0.016	0.984	0.000
T36.2 Chloramphenicol group	0.016	0.984	0.000
T36.4 Tetracyclines	0.016	0.984	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.016	0.984	0.000
T36.0 Penicillins	0.016	0.984	0.000
T41.5 Therapeutic gases	0.016	0.984	0.000
T41.4 Anaesthetic, unspecified	0.016	0.984	0.000
T41.3 Local anaesthetics	0.016	0.984	0.000
T41.2 Other and unspecified general anaesthetics	0.016	0.984	0.000
T41.1 Intravenous anaesthetics	0.016	0.984	0.000
T41.0 Inhaled anaesthetics	0.016	0.984	0.000
T40.1 Heroin	0.016	0.984	0.000
T40.4 Other synthetic narcotics	0.016	0.984	0.000
T47.6 Antidiarrhoeal drugs	0.015	0.984	0.000
T38.0 Glucocorticoids and synthetic analogues	0.015	0.984	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.015	0.985	0.000
T37.5 Antiviral drugs	0.015	0.985	0.000
T37.4 Anthelminthics	0.015	0.985	0.000
T37.3 Other antiprotozoal drugs	0.015	0.985	0.000
T37.1 Antimycobacterial drugs	0.015	0.985	0.000
T37.0 Sulphonamides	0.015	0.985	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.015	0.985	0.000
T38.9 Other and unspecified hormone antagonists	0.015	0.985	0.000
T38.7 Androgens and anabolic congeners	0.015	0.985	0.000
T38.5 Other oestrogens and progestogens	0.015	0.985	0.000
T38.4 Oral contraceptives	0.015	0.985	0.000
T38.2 Antithyroid drugs	0.015	0.985	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.015	0.985	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.015	0.985	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.015	0.985	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.015	0.985	0.000
T47.7 Emetics	0.015	0.985	0.000
T47.5 Digestants	0.015	0.985	0.000
T47.3 Saline and osmotic laxatives	0.015	0.985	0.000
T45.0 Antiallergic and antiemetic drugs	0.014	0.985	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.014	0.986	0.000
T47.4 Other laxatives	0.014	0.986	0.000
T47.0 Histamine H(2)-receptor antagonists	0.013	0.986	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.013	0.987	0.000
I64 Stroke, not specified as haemorrhage or infarction	0.012	0.988	0.000
T47.2 Stimulant laxatives	0.012	0.988	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.011	0.989	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.010	0.990	0.000
S06.40 Epidural haemorrhage (without open intracranial wound)	0.000	0.990	0.010
T43.9 Psychotropic drug, unspecified	0.010	0.990	0.000
I60-I69 Cerebrovascular diseases	0.010	0.990	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.010	0.990	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.010	0.990	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.010	0.990	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.010	0.990	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.010	0.990	0.000
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction	0.009	0.991	0.000
T43.6 Psychostimulants with abuse potential	0.008	0.991	0.000
T42.0 Hydantoin derivatives	0.008	0.992	0.000
I69.0 Sequelae of subarachnoid haemorrhage	0.008	0.992	0.001
I65.2 Occlusion and stenosis of carotid artery	0.008	0.992	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.008	0.992	0.000
I68 Cerebrovascular disorders in diseases classified elsewhere	0.008	0.992	0.000
M65.95 Synovitis and tenosynovitis, unspecified (Pelvic region and thigh)	0.000	0.992	0.008
I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction	0.007	0.993	0.000
M65.91 Synovitis and tenosynovitis, unspecified (Shoulder region)	0.000	0.993	0.007
I65.1 Occlusion and stenosis of basilar artery	0.007	0.993	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.007	0.993	0.000
T42.2 Succinimides and oxazolidinediones	0.007	0.993	0.000
M65.9 Synovitis and tenosynovitis, unspecified	0.000	0.993	0.007
I61 Intracerebral haemorrhage	0.007	0.993	0.000
I65.0 Occlusion and stenosis of vertebral artery	0.007	0.993	0.000
T42.3 Barbiturates	0.007	0.993	0.000
K63.3 Ulcer of intestine	0.007	0.993	0.000
O61.0 Failed medical induction of labour	0.000	0.993	0.007
M65.93 Synovitis and tenosynovitis, unspecified (Forearm)	0.000	0.993	0.007
I65.9 Occlusion and stenosis of unspecified precerebral artery	0.007	0.993	0.000
T42.1 Iminostilbenes	0.006	0.994	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.006	0.994	0.000
M54.36 Sciatica (Lumbar region)	0.006	0.994	0.000
M65.92 Synovitis and tenosynovitis, unspecified (Upper arm)	0.000	0.994	0.006
M65.99 Synovitis and tenosynovitis, unspecified (Site unspecified)	0.000	0.994	0.006
I61.5 Intracerebral haemorrhage, intraventricular	0.006	0.994	0.000
I61.2 Intracerebral haemorrhage in hemisphere, unspecified	0.006	0.994	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.006	0.994	0.000
I65.8 Occlusion and stenosis of other precerebral artery	0.006	0.994	0.000
D72.8 Other specified disorders of white blood cells	0.000	0.994	0.006
I61.4 Intracerebral haemorrhage in cerebellum	0.006	0.994	0.000
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.006	0.994	0.000
I68.0 Cerebral amyloid angiopathy	0.006	0.994	0.000
I66.9 Occlusion and stenosis of unspecified cerebral artery	0.006	0.994	0.000
S06.4 Epidural haemorrhage	0.000	0.994	0.006
I66.0 Occlusion and stenosis of middle cerebral artery	0.006	0.994	0.000
M31.6 Other giant cell arteritis	0.000	0.994	0.006
I65.3 Occlusion and stenosis of multiple and bilateral precerebral arteries	0.006	0.994	0.000
I68.8 Other cerebrovascular disorders in diseases classified elsewhere	0.006	0.994	0.000
I68.2 Cerebral arteritis in other diseases classified elsewhere	0.006	0.994	0.000
I68.1 Cerebral arteritis in infectious and parasitic diseases classified elsewhere	0.006	0.994	0.000
M65.90 Synovitis and tenosynovitis, unspecified (Multiple sites)	0.000	0.994	0.006
I66.2 Occlusion and stenosis of posterior cerebral artery	0.006	0.994	0.000
I66.8 Occlusion and stenosis of other cerebral artery	0.005	0.994	0.000
I66.1 Occlusion and stenosis of anterior cerebral artery	0.005	0.994	0.000
I66.3 Occlusion and stenosis of cerebellar arteries	0.005	0.994	0.000
M65.98 Synovitis and tenosynovitis, unspecified (Other)	0.000	0.994	0.005
M65.97 Synovitis and tenosynovitis, unspecified (Ankle and foot)	0.000	0.995	0.005
I67 Other cerebrovascular diseases	0.005	0.995	0.000
M65.94 Synovitis and tenosynovitis, unspecified (Hand)	0.000	0.995	0.005
I67.1 Cerebral aneurysm, nonruptured	0.000	0.995	0.005
I61.9 Intracerebral haemorrhage, unspecified	0.005	0.995	0.000
M31.3 Wegener's granulomatosis	0.000	0.995	0.005
I67.2 Cerebral atherosclerosis	0.005	0.995	0.000
I61.3 Intracerebral haemorrhage in brain stem	0.005	0.995	0.000
M31 Other necrotising vasculopathies	0.000	0.995	0.005
I66.4 Occlusion and stenosis of multiple and bilateral cerebral arteries	0.005	0.995	0.000
I61.6 Intracerebral haemorrhage, multiple localised	0.005	0.995	0.000
Z36 Antenatal screening	0.005	0.995	0.000
I67.9 Cerebrovascular disease, unspecified	0.005	0.995	0.000
I61.8 Other intracerebral haemorrhage	0.005	0.995	0.000
I61.0 Intracerebral haemorrhage in hemisphere, subcortical	0.005	0.995	0.000
T42.4 Benzodiazepines	0.005	0.995	0.000
M54.3 Sciatica	0.005	0.995	0.000
Z36.0 Antenatal screening for chromosomal anomalies	0.005	0.995	0.000
S06.41 Epidural haemorrhage (with open intracranial wound)	0.000	0.995	0.004
C15.5 Lower third of oesophagus	0.000	0.995	0.005
M31.5 Giant cell arteritis with polymyalgia rheumatica	0.000	0.996	0.004
I67.4 Hypertensive encephalopathy	0.004	0.996	0.000
I61.1 Intracerebral haemorrhage in hemisphere, cortical	0.004	0.996	0.000
M31.7 Microscopic polyangiitis	0.000	0.996	0.004
M31.1 Thrombotic microangiopathy	0.000	0.996	0.004
I62 Other nontraumatic intracranial haemorrhage	0.004	0.996	0.000
M54.37 Sciatica (Lumbosacral region)	0.004	0.996	0.000
I67.6 Nonpyogenic thrombosis of intracranial venous system	0.004	0.996	0.000
I67.5 Moyamoya disease	0.004	0.996	0.000
I67.3 Progressive vascular leukoencephalopathy	0.004	0.996	0.000
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.004	0.996	0.000
O61 Failed induction of labour	0.000	0.996	0.004
M54.38 Sciatica (Sacral and sacrococcygeal region)	0.004	0.996	0.000
M31.4 Aortic arch syndrome [Takayasu]	0.000	0.996	0.004
I67.0 Dissection of cerebral arteries, nonruptured	0.004	0.996	0.000
M31.2 Lethal midline granuloma	0.000	0.996	0.004
M31.0 Hypersensitivity angiitis	0.000	0.996	0.004
I67.7 Cerebral arteritis, not elsewhere classified	0.004	0.996	0.000
Z36.8 Other antenatal screening	0.004	0.996	0.000
Z36.9 Antenatal screening, unspecified	0.004	0.996	0.000
Z36.1 Antenatal screening for raised alphafetoprotein level	0.004	0.996	0.000
Z36.5 Antenatal screening for isoimmunisation	0.004	0.996	0.000
Z36.2 Other antenatal screening based on amniocentesis	0.004	0.996	0.000
M54.39 Sciatica (Site unspecified)	0.004	0.996	0.000
M54.35 Sciatica (Thoracolumbar region)	0.003	0.996	0.000
M54.34 Sciatica-Thoracic	0.003	0.996	0.000
M54.33 Sciatica-Cervicothoracic	0.003	0.996	0.000
M54.32 Sciatica-Cervical	0.003	0.996	0.000
M54.31 Sciatica-Occipit-atl-axl	0.003	0.996	0.000
M31.8 Other specified necrotising vasculopathies	0.000	0.996	0.003
T43.2 Other and unspecified antidepressants	0.004	0.996	0.000
C90.0 Multiple myeloma	0.000	0.997	0.003
M54.30 Sciatica (Multiple sites in spine)	0.003	0.997	0.000
O61.9 Failed induction of labour, unspecified	0.000	0.997	0.003
O61.1 Failed instrumental induction of labour	0.000	0.997	0.003
I60 Subarachnoid haemorrhage	0.003	0.997	0.000
I60.8 Other subarachnoid haemorrhage	0.003	0.997	0.000
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)	0.000	0.997	0.003
I62.1 Nontraumatic extradural haemorrhage	0.003	0.997	0.000
M20.6 Acquired deformity of toe(s), unspecified	0.000	0.997	0.003
B00.1 Herpesviral vesicular dermatitis	0.000	0.997	0.003
F10.2 Dependence syndrome	0.003	0.997	0.000
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.003	0.997	0.000
O61.8 Other failed induction of labour	0.000	0.997	0.003
C32.1 Supraglottis	0.003	0.997	0.000
A63.0 Anogenital (venereal) warts	0.003	0.997	0.000
C32.9 Larynx, unspecified	0.003	0.997	0.000
M31.9 Necrotising vasculopathy, unspecified	0.000	0.997	0.003
F32.1 Moderate depressive episode	0.003	0.997	0.000
S06.6 Traumatic subarachnoid haemorrhage	0.000	0.997	0.003
G40.3 Generalised idiopathic epilepsy and epileptic syndromes	0.003	0.997	0.000
L85.8 Other specified epidermal thickening	0.003	0.997	0.000
C32 Malignant neoplasm of larynx	0.003	0.997	0.000
I60.2 Subarachnoid haemorrhage from anterior communicating artery	0.003	0.997	0.000
D23.4 Skin of scalp and neck	0.003	0.997	0.000
Z95.8 Presence of other cardiac and vascular implants and grafts	0.003	0.997	0.000
I60.5 Subarachnoid haemorrhage from vertebral artery	0.003	0.997	0.000
K75.0 Abscess of liver	0.003	0.997	0.000
I89.8 Other specified non-infective disorders of lymphatic vessels and lymph nodes	0.000	0.997	0.003
C78.2 Secondary malignant neoplasm of pleura	0.000	0.997	0.003
C32.0 Glottis	0.003	0.997	0.000
I62.9 Intracranial haemorrhage (nontraumatic), unspecified	0.002	0.997	0.000
H71 Cholesteatoma of middle ear	0.000	0.997	0.003
I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation	0.002	0.997	0.000
S06 Intracranial injury	0.000	0.997	0.003
I73.9 Peripheral vascular disease, unspecified	0.003	0.997	0.000
W08.0 Home	0.003	0.997	0.000
I60.3 Subarachnoid haemorrhage from posterior communicating artery	0.002	0.997	0.000
D43.2 Brain, unspecified	0.000	0.997	0.003
I60.4 Subarachnoid haemorrhage from basilar artery	0.002	0.997	0.000
C90.1 Plasma cell leukaemia	0.000	0.998	0.002
R76.8 Other specified abnormal immunological findings in serum	0.002	0.998	0.000
L85.9 Epidermal thickening, unspecified	0.002	0.998	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.000	0.998	0.002
M65.96 Synovitis and tenosynovitis, unspecified (Lower leg)	0.000	0.998	0.002
S06.61 Traumatic subarachnoid haemorrhage (with open intracranial wound)	0.000	0.998	0.002
S83.2 Tear of meniscus, current	0.000	0.998	0.002
S32.40 Fracture of acetabulum (closed)	0.000	0.998	0.002
C32.2 Subglottis	0.002	0.998	0.000
C90.2 Plasmacytoma, extramedullary	0.000	0.998	0.002
I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified	0.002	0.998	0.000
I60.6 Subarachnoid haemorrhage from other intracranial arteries	0.002	0.998	0.000
K56.7 Ileus, unspecified	0.002	0.998	0.000
C32.8 Overlapping lesion of larynx	0.002	0.998	0.000
C32.3 Laryngeal cartilage	0.002	0.998	0.000
X68.9 Unspecified place	0.002	0.998	0.000
S06.0 Concussion	0.000	0.998	0.002
G40 Epilepsy	0.002	0.998	0.000
C71.8 Overlapping lesion of brain	0.000	0.998	0.002
N19 Unspecified renal failure	0.000	0.998	0.002
G40.8 Other epilepsy	0.002	0.998	0.000
S06.9 Intracranial injury, unspecified	0.000	0.998	0.002
S06.7 Intracranial injury with prolonged coma	0.000	0.998	0.002
X69.9 Unspecified place	0.002	0.998	0.000
M85.65 Other cyst of bone (Pelvic region and thigh)	0.002	0.998	0.000
G40.5 Special epileptic syndromes	0.002	0.998	0.000
F10.3 Withdrawal state	0.002	0.998	0.000
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures	0.002	0.998	0.000
F41.1 Generalised anxiety disorder	0.002	0.998	0.000
G40.4 Other generalised epilepsy and epileptic syndromes	0.002	0.998	0.000
L85 Other epidermal thickening	0.002	0.998	0.000
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances	0.002	0.998	0.000
N48.4 Impotence of organic origin	0.002	0.998	0.000
S06.00 Concussion (without open intracranial wound)	0.000	0.998	0.002
X68 Intentional self-poisoning by and exposure to pesticides	0.002	0.998	0.000
I67.8 Other specified cerebrovascular diseases	0.002	0.998	0.000
X69.0 Home	0.002	0.998	0.000
C30.0 Nasal cavity	0.002	0.998	0.000
S06.8 Other intracranial injuries	0.000	0.998	0.002
S06.1 Traumatic cerebral oedema	0.000	0.998	0.002
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified	0.000	0.998	0.002
Z50.4 Psychotherapy, not elsewhere classified	0.000	0.998	0.002
S06.01 Concussion (with open intracranial wound)	0.000	0.998	0.002
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset	0.002	0.998	0.000
C15 Malignant neoplasm of oesophagus	0.000	0.998	0.002
C71.9 Brain, unspecified	0.000	0.998	0.002
I20.8 Other forms of angina pectoris	0.002	0.998	0.000
M85.6 Other cyst of bone	0.002	0.998	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.002	0.998	0.000
M85.67 Other cyst of bone (Ankle and foot)	0.002	0.998	0.000
S06.2 Diffuse brain injury	0.000	0.998	0.002
A63 Other predominantly sexually transmitted diseases, not elsewhere classified	0.002	0.998	0.000
S06.71 Intracranial injury with prolonged coma (with open intracranial wound)	0.000	0.998	0.002
S06.70 Intracranial injury with prolonged coma (without open intracranial wound)	0.000	0.998	0.002
S06.91 Intracranial injury, unspecified (with open intracranial wound)	0.000	0.998	0.002
S06.3 Focal brain injury	0.000	0.998	0.002
D72 Other disorders of white blood cells	0.000	0.998	0.002
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
S06.90 Intracranial injury, unspecified (without open intracranial wound)	0.000	0.998	0.002
F05.9 Delirium, unspecified	0.002	0.998	0.000
R94.3 Abnormal results of cardiovascular function studies	0.000	0.998	0.002
X60-X84 Intentional self-harm	0.002	0.998	0.000
D44.3 Pituitary gland	0.002	0.998	0.000
L85.3 Xerosis cutis	0.002	0.998	0.000
L85.2 Keratosis punctata (palmaris et plantaris)	0.002	0.998	0.000
L85.0 Acquired ichthyosis	0.002	0.998	0.000
X69.8 Other specified place	0.002	0.998	0.000
X69.7 Farm	0.002	0.998	0.000
X69.6 Industrial and construction area	0.002	0.998	0.000
X69.5 Trade and service area	0.002	0.998	0.000
X69.4 Street and highway	0.002	0.998	0.000
X69.3 Sports and athletics area	0.002	0.998	0.000
X69.2 School, other institution and public administrative area	0.002	0.998	0.000
X69.1 Residential institution	0.002	0.998	0.000
M85.64 Other cyst of bone (Hand)	0.002	0.998	0.000
C90.3 Solitary plasmacytoma	0.000	0.998	0.002
Q61.0 Congenital single renal cyst	0.000	0.998	0.002
C15.4 Middle third of oesophagus	0.000	0.998	0.002
L85.1 Acquired keratosis [keratoderma] palmaris et plantaris	0.002	0.998	0.000
S06.5 Traumatic subdural haemorrhage	0.000	0.998	0.002
X61.4 Street and highway	0.002	0.998	0.000
X68.8 Other specified place	0.002	0.998	0.000
X68.7 Farm	0.002	0.998	0.000
X68.6 Industrial and construction area	0.002	0.998	0.000
X68.5 Trade and service area	0.002	0.998	0.000
X68.4 Street and highway	0.002	0.998	0.000
X68.3 Sports and athletics area	0.002	0.998	0.000
X68.2 School, other institution and public administrative area	0.002	0.998	0.000
X68.1 Residential institution	0.002	0.998	0.000
X68.0 Home	0.002	0.998	0.000
M54.49 Lumbago with sciatica (Site unspecified)	0.002	0.998	0.000
M85.66 Other cyst of bone (Lower leg)	0.002	0.998	0.000
T93.8 Sequelae of other specified injuries of lower limb	0.000	0.998	0.002
X61.2 School, other institution and public administrative area	0.002	0.998	0.000
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.002	0.998	0.000
S06.11 Traumatic cerebral oedema (with open intracranial wound)	0.000	0.998	0.001
S06.81 Other intracranial injuries (with open intracranial wound)	0.000	0.998	0.001
T92.1 Sequelae of fracture of arm	0.002	0.998	0.000
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.002	0.998	0.000
M85.68 Other cyst of bone (Other)	0.002	0.998	0.000
O86.4 Pyrexia of unknown origin following delivery	0.002	0.998	0.000
G97.8 Other postprocedural disorders of nervous system	0.000	0.998	0.002
I60.1 Subarachnoid haemorrhage from middle cerebral artery	0.001	0.998	0.001
L53.9 Erythematous condition, unspecified	0.000	0.998	0.002
X64 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
M79.96 Soft tissue disorder, unspecified (Lower leg)	0.002	0.998	0.000
A63.8 Other specified predominantly sexually transmitted diseases	0.002	0.998	0.000
C15.1 Thoracic part of oesophagus	0.000	0.998	0.002
O47.0 False labour before 37 completed weeks of gestation	0.002	0.998	0.000
T92.2 Sequelae of fracture at wrist and hand level	0.002	0.998	0.000
N12 Tubulo-interstitial nephritis, not specified as acute or chronic	0.002	0.998	0.000
C15.8 Overlapping lesion of oesophagus	0.000	0.998	0.001
C15.2 Abdominal part of oesophagus	0.000	0.998	0.001
G54.0 Brachial plexus disorders	0.000	0.998	0.002
T92.8 Sequelae of other specified injuries of upper limb	0.002	0.998	0.000
X60.2 School, other institution and public administrative area	0.002	0.998	0.000
X63.0 Home	0.002	0.998	0.000
C30 Malignant neoplasm of nasal cavity and middle ear	0.002	0.998	0.000
M85.69 Other cyst of bone (Site unspecified)	0.001	0.998	0.000
M85.63 Other cyst of bone (Forearm)	0.001	0.998	0.000
M85.62 Other cyst of bone (Upper arm)	0.001	0.998	0.000
M85.61 Other cyst of bone (Shoulder region)	0.001	0.998	0.000
M85.60 Other cyst of bone (Multiple sites)	0.001	0.998	0.000
F10 Mental and behavioural disorders due to use of alcohol	0.002	0.998	0.000
X78 Intentional self-harm by sharp object	0.002	0.998	0.000
O87.2 Haemorrhoids in the puerperium	0.002	0.998	0.000
X65 Intentional self-poisoning by and exposure to alcohol	0.001	0.998	0.000
S06.21 Diffuse brain injury (with open intracranial wound)	0.000	0.998	0.001
D72.9 Disorder of white blood cells, unspecified	0.000	0.998	0.001
D72.0 Genetic anomalies of leukocytes	0.000	0.998	0.001
G57.8 Other mononeuropathies of lower limb	0.002	0.998	0.000
X60.5 Trade and service area	0.001	0.998	0.000
X61.9 Unspecified place	0.001	0.998	0.000
X61.8 Other specified place	0.001	0.998	0.000
X61.0 Home	0.001	0.998	0.000
X61.7 Farm	0.001	0.998	0.000
X61.6 Industrial and construction area	0.001	0.998	0.000
X61.5 Trade and service area	0.001	0.998	0.000
X61.3 Sports and athletics area	0.001	0.998	0.000
X61.1 Residential institution	0.001	0.998	0.000
X64.2 School, other institution and public administrative area	0.001	0.998	0.000
X83 Intentional self-harm by other specified means	0.001	0.998	0.000
X80 Intentional self-harm by jumping from a high place	0.001	0.998	0.000
S06.31 Focal brain injury (with open intracranial wound)	0.000	0.998	0.001
F10.7 Residual and late-onset psychotic disorder	0.001	0.998	0.000
F10.5 Psychotic disorder	0.002	0.998	0.000
K75.9 Inflammatory liver disease, unspecified	0.002	0.998	0.000
X82 Intentional self-harm by crashing of motor vehicle	0.001	0.998	0.000
X81 Intentional self-harm by jumping or lying before moving object	0.001	0.998	0.000
X79 Intentional self-harm by blunt object	0.001	0.998	0.000
X77 Intentional self-harm by steam, hot vapours and hot objects	0.001	0.998	0.000
X76 Intentional self-harm by smoke, fire and flames	0.001	0.998	0.000
X75 Intentional self-harm by explosive material	0.001	0.998	0.000
X74 Intentional self-harm by other and unspecified firearm discharge	0.001	0.998	0.000
X73 Intentional self-harm by rifle, shotgun and larger firearm discharge	0.001	0.998	0.000
X72 Intentional self-harm by handgun discharge	0.001	0.998	0.000
X71 Intentional self-harm by drowning and submersion	0.001	0.998	0.000
X66 Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours	0.001	0.998	0.000
C15.0 Cervical part of oesophagus	0.000	0.998	0.001
X70 Intentional self-harm by hanging, strangulation and suffocation	0.001	0.998	0.000
H58.8 Visual disturbances in diseases classified elsewhere	0.002	0.998	0.000
W07.9 Unspecified place	0.002	0.998	0.000
S06.10 Traumatic cerebral oedema (without open intracranial wound)	0.000	0.998	0.001
S06.51 Traumatic subdural haemorrhage (with open intracranial wound)	0.000	0.998	0.001
K75 Other inflammatory liver diseases	0.002	0.998	0.000
K75.4 Autoimmune hepatitis	0.001	0.998	0.000
T92 Sequelae of injuries of upper limb	0.002	0.998	0.000
B00.4 Herpesviral encephalitis	0.000	0.998	0.001
C15.9 Oesophagus, unspecified	0.000	0.998	0.002
I89.9 Non-infective disorder of lymphatic vessels and lymph nodes, unspecified	0.000	0.998	0.001
T92.0 Sequelae of open wound of upper limb	0.001	0.998	0.000
W60.0 Home	0.001	0.998	0.000
X60.9 Unspecified place	0.001	0.998	0.000
X60.0 Home	0.001	0.998	0.000
X60.7 Farm	0.001	0.998	0.000
X60.6 Industrial and construction area	0.001	0.998	0.000
X60.4 Street and highway	0.001	0.998	0.000
X60.3 Sports and athletics area	0.001	0.998	0.000
X60.1 Residential institution	0.001	0.998	0.000
X63.9 Unspecified place	0.001	0.998	0.000
X63.8 Other specified place	0.001	0.998	0.000
X63.7 Farm	0.001	0.998	0.000
X63.6 Industrial and construction area	0.001	0.998	0.000
X63.5 Trade and service area	0.001	0.998	0.000
X63.4 Street and highway	0.001	0.998	0.000
X63.3 Sports and athletics area	0.001	0.998	0.000
X63.2 School, other institution and public administrative area	0.001	0.998	0.000
X63.1 Residential institution	0.001	0.998	0.000
S06.80 Other intracranial injuries (without open intracranial wound)	0.000	0.999	0.001
J38.1 Polyp of vocal cord and larynx	0.001	0.999	0.000
X64.9 Unspecified place	0.001	0.999	0.000
X64.0 Home	0.001	0.999	0.000
X64.8 Other specified place	0.001	0.999	0.000
X64.7 Farm	0.001	0.999	0.000
X64.6 Industrial and construction area	0.001	0.999	0.000
X64.5 Trade and service area	0.001	0.999	0.000
X64.4 Street and highway	0.001	0.999	0.000
X64.3 Sports and athletics area	0.001	0.999	0.000
X64.1 Residential institution	0.001	0.999	0.000
Z63.0 Problems in relationship with spouse or partner	0.001	0.999	0.000
C30.1 Middle ear	0.001	0.999	0.000
G54.4 Lumbosacral root disorders, not elsewhere classified	0.000	0.999	0.001
S01.5 Open wound of lip and oral cavity	0.000	0.999	0.001
X70.0 Home	0.001	0.999	0.000
X78.0 Home	0.001	0.999	0.000
X84 Intentional self-harm by unspecified means	0.001	0.999	0.000
M54.64 Pain in thoracic spine (Thoracic region)	0.001	0.999	0.000
C15.3 Upper third of oesophagus	0.000	0.999	0.001
F10.6 Amnesic syndrome	0.001	0.999	0.000
F10.4 Withdrawal state with delirium	0.001	0.999	0.000
G40.7 Petit mal, unspecified, without grand mal seizures	0.001	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations